A Phase 2 PoC in IBS Patients With the CRF1 Receptor Anatgonist, GSK876008

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT00421707

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:36:41.487927+00:00

Published At

2017-12-26T00:00:00+00:00

Record Updated At

2018-01-31

Results Posted At

2017-12-26

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Irritable Bowel Syndrome (IBS)"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2018-01-31"

protocolSection.identificationModule.nctId

"NCT00421707"

protocolSection.identificationModule.officialTitle

"A Phase 2 PoC in IBS Patients With the CRF1 Receptor Anatgonist, GSK876008"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

"2017-12-26"

Study condition terms

• Irritable Bowel Syndrome (IBS) (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.